PGNY
Progyny, Inc. NASDAQ Listed Oct 25, 2019$19.17
Mkt Cap $1.6B
52w Low $16.10
24.3% of range
52w High $28.75
50d MA $17.91
200d MA $21.80
P/E (TTM)
27.4x
EV/EBITDA
20.9x
P/B
3.1x
Debt/Equity
0.1x
ROE
2.4%
P/FCF
11.4x
RSI (14)
—
ATR (14)
—
Beta
0.99
50d MA
$17.91
200d MA
$21.80
Avg Volume
1.5M
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
1359 Broadway · New York City, NY 10018 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | 0.15 | 0.15 | +2.0% | 22.25 | -10.7% | -20.5% | -20.9% | -21.3% | -20.0% | -20.8% | — |
| Nov 6, 2025 | AMC | 0.39 | 0.45 | +15.4% | 18.01 | +14.8% | +24.2% | +31.1% | +32.2% | +33.6% | +35.6% | — |
| Aug 7, 2025 | AMC | 0.44 | 0.48 | +9.1% | 23.06 | +13.7% | -0.9% | -5.7% | -5.6% | +0.0% | -2.2% | — |
| May 8, 2025 | AMC | 0.45 | 0.48 | +6.7% | 23.37 | -2.6% | -9.3% | -5.9% | -7.2% | -6.5% | -6.1% | — |
| Feb 27, 2025 | AMC | 0.37 | 0.42 | +13.5% | 22.88 | +16.0% | -1.5% | -3.8% | -5.8% | -5.2% | -8.0% | — |
| Nov 12, 2024 | AMC | 0.37 | 0.40 | +8.1% | 17.18 | -13.3% | -19.1% | -18.6% | -19.8% | -19.1% | -20.4% | — |
| Aug 6, 2024 | AMC | 0.36 | 0.43 | +19.4% | 25.74 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% | — |
| May 9, 2024 | AMC | 0.14 | 0.39 | +178.6% | 32.50 | -26.5% | -15.3% | -15.7% | -15.4% | -17.6% | -15.2% | — |
| Feb 27, 2024 | AMC | 0.11 | 0.32 | +190.9% | 40.79 | -11.3% | -15.1% | -10.5% | -11.7% | -13.0% | -15.4% | — |
| Nov 7, 2023 | AMC | 0.12 | 0.16 | +33.3% | 32.00 | +0.0% | -7.8% | -7.5% | -5.7% | -4.8% | -0.5% | — |
| Aug 3, 2023 | AMC | 0.10 | 0.15 | +50.0% | 40.43 | +3.9% | +6.1% | +1.4% | -1.6% | -3.4% | -6.5% | — |
| May 8, 2023 | AMC | 0.07 | 0.18 | +157.1% | 34.85 | +3.9% | +8.5% | +7.7% | +4.7% | +5.1% | +3.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Barclays | Maintains | Overweight → Overweight | — | $18.18 | $18.17 | -0.1% | -0.3% | -0.9% | -0.7% | -2.4% | -2.1% |
| Mar 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $17.91 | $17.65 | -1.5% | -2.2% | -2.3% | -2.3% | -2.7% | +0.8% |
| Mar 5 | BTIG | Maintains | Buy → Buy | — | $17.79 | $17.67 | -0.7% | -1.0% | +2.9% | +2.6% | +0.7% | -1.6% |
| Mar 2 | Truist | Maintains | Buy → Buy | — | $17.69 | $17.27 | -2.4% | -0.5% | -1.0% | +0.6% | -0.4% | +3.5% |
| Mar 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $17.69 | $17.27 | -2.4% | -0.5% | -1.0% | +0.6% | -0.4% | +3.5% |
| Jan 20 | Citizens | Upgrade | Market Perform → Market Outperform | — | $24.52 | $25.05 | +2.2% | +3.5% | +3.8% | +2.0% | +2.9% | +1.3% |
| Jan 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $26.80 | $27.51 | +2.6% | +2.4% | +0.7% | +6.0% | -5.8% | -2.5% |
| Nov 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $24.55 | $25.50 | +3.9% | +9.2% | +5.3% | +3.5% | +1.1% | +5.3% |
| Nov 12 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $23.81 | $24.32 | +2.1% | +1.1% | +2.6% | +3.1% | +12.6% | +8.6% |
| Nov 11 | JP Morgan | Maintains | Neutral → Neutral | — | $23.62 | $23.79 | +0.7% | +0.8% | +1.9% | +3.4% | +3.9% | +13.5% |
| Aug 26 | JP Morgan | Maintains | Neutral → Neutral | — | $23.14 | $23.07 | -0.3% | -2.2% | -0.5% | +0.5% | +2.3% | +1.2% |
| Aug 20 | Canaccord Genuity | Maintains | Hold → Hold | — | $22.74 | $22.80 | +0.3% | -0.8% | +1.7% | +3.5% | +1.8% | -0.4% |
| Aug 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $23.06 | $26.21 | +13.7% | -0.9% | -5.7% | -5.6% | +0.0% | -2.2% |
| Jul 17 | Truist | Maintains | Hold → Hold | — | $23.02 | $23.01 | -0.0% | -0.0% | -4.4% | -0.3% | -0.2% | +1.9% |
| Jul 8 | Leerink Partners | Upgrade | Market Perform → Outperform | — | $21.45 | $21.66 | +1.0% | +13.1% | +10.9% | +10.1% | +8.2% | +9.4% |
| May 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $21.19 | $21.20 | +0.0% | +3.8% | +2.3% | +3.2% | +3.6% | +5.2% |
| Mar 31 | BTIG | Upgrade | Neutral → Buy | — | $21.90 | $22.13 | +1.1% | +2.0% | +5.4% | +4.9% | +5.7% | +3.2% |
| Feb 28 | Canaccord Genuity | Maintains | Hold → Hold | — | $22.88 | $26.55 | +16.0% | -1.5% | -3.8% | -5.8% | -5.2% | -8.0% |
| Feb 11 | BofA Securities | Maintains | Buy → Buy | — | $22.35 | $22.74 | +1.7% | +0.2% | -1.5% | -1.8% | +0.0% | +2.0% |
| Jan 28 | JP Morgan | Maintains | Neutral → Neutral | — | $22.95 | $22.93 | -0.1% | +2.8% | +1.3% | +2.6% | +1.0% | +2.8% |
| Dec 2 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.57 | $15.20 | -2.4% | +0.1% | -4.6% | -4.4% | -3.7% | -5.2% |
| Nov 14 | Barclays | Maintains | Overweight → Overweight | — | $13.90 | $13.91 | +0.1% | +0.6% | -0.9% | +0.0% | -1.7% | +0.6% |
| Nov 13 | Canaccord Genuity | Maintains | Hold → Hold | — | $17.18 | $14.90 | -13.3% | -19.1% | -18.6% | -19.8% | -19.1% | -20.4% |
| Nov 13 | BofA Securities | Maintains | Buy → Buy | — | $17.18 | $14.90 | -13.3% | -19.1% | -18.6% | -19.8% | -19.1% | -20.4% |
| Nov 13 | Truist | Downgrade | Buy → Hold | — | $17.18 | $14.90 | -13.3% | -19.1% | -18.6% | -19.8% | -19.1% | -20.4% |
| Oct 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $16.76 | $16.89 | +0.8% | -3.5% | -2.6% | -5.6% | -2.7% | -4.0% |
| Sep 20 | Canaccord Genuity | Maintains | Hold → Hold | — | $16.46 | $16.35 | -0.7% | +1.0% | +4.4% | +4.2% | +1.2% | +1.6% |
| Sep 19 | JP Morgan | Maintains | Overweight → Overweight | — | $24.44 | $17.60 | -28.0% | -32.7% | -32.0% | -29.7% | -29.8% | -31.9% |
| Sep 19 | Jefferies | Maintains | Buy → Buy | — | $24.44 | $17.60 | -28.0% | -32.7% | -32.0% | -29.7% | -29.8% | -31.9% |
| Sep 19 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $24.44 | $17.60 | -28.0% | -32.7% | -32.0% | -29.7% | -29.8% | -31.9% |
| Sep 19 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $24.44 | $17.60 | -28.0% | -32.7% | -32.0% | -29.7% | -29.8% | -31.9% |
| Sep 19 | Truist | Maintains | Buy → Buy | — | $24.44 | $17.60 | -28.0% | -32.7% | -32.0% | -29.7% | -29.8% | -31.9% |
| Sep 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $24.44 | $17.60 | -28.0% | -32.7% | -32.0% | -29.7% | -29.8% | -31.9% |
| Aug 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $21.18 | $21.14 | -0.2% | -0.6% | +1.8% | -0.8% | +2.9% | +2.5% |
| Aug 19 | JP Morgan | Maintains | Overweight → Overweight | — | $21.04 | $21.05 | +0.0% | +0.7% | +0.1% | +2.5% | -0.1% | +3.6% |
| Aug 7 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $25.74 | $21.00 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% |
| Aug 7 | Canaccord Genuity | Downgrade | Buy → Hold | — | $25.74 | $21.00 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% |
| Aug 7 | BTIG | Downgrade | Buy → Neutral | — | $25.74 | $21.00 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% |
| Aug 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $25.74 | $21.00 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% |
| Aug 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $25.74 | $21.00 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% |
| Aug 7 | Truist | Maintains | Buy → Buy | — | $25.74 | $21.00 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% |
| May 17 | Truist | Maintains | Buy → Buy | — | $27.55 | $27.54 | -0.0% | +2.0% | +1.6% | -0.3% | -2.9% | -1.5% |
| May 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $26.78 | $26.81 | +0.1% | +2.9% | +4.9% | +4.6% | +2.5% | -0.1% |
| May 13 | Barclays | Maintains | Overweight → Overweight | — | $27.53 | $27.74 | +0.8% | -0.5% | -0.2% | -2.7% | +0.1% | +2.0% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.50 | $23.90 | -26.5% | -15.3% | -15.7% | -15.4% | -17.6% | -15.2% |
| May 10 | BTIG | Maintains | Buy → Buy | — | $32.50 | $23.90 | -26.5% | -15.3% | -15.7% | -15.4% | -17.6% | -15.2% |
| May 10 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $32.50 | $23.90 | -26.5% | -15.3% | -15.7% | -15.4% | -17.6% | -15.2% |
| Apr 17 | Truist | Maintains | Buy → Buy | — | $33.39 | $33.62 | +0.7% | -1.9% | -4.5% | -2.1% | -1.0% | -3.0% |
| Feb 28 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $40.79 | $36.18 | -11.3% | -15.1% | -10.5% | -11.7% | -13.0% | -15.4% |
| Feb 28 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $40.79 | $36.18 | -11.3% | -15.1% | -10.5% | -11.7% | -13.0% | -15.4% |
No insider trades available.
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Progyny faces shareholder litigation settlement that could provide legal closure and reduce future liability exposure, though settlement terms remain undisclosed pending court approval.
Mar 13
8-K · 7.01
! Medium
Progyny, Inc. -- 8-K 7.01: Regulation FD Disclosure
Progyny disclosed earnings results and supplemental presentation materials via 8-K filing, providing investors with detailed financial performance information and forward-looking guidance on its investor relations website.
Feb 26
Data updated apr 26, 2026 7:29pm
· Source: massive.com